CVS Health Corporation Has Delivered Strong Results for Investors

Trending News ☀️

CVS ($NYSE:CVS) Health Corporation has delivered strong results for investors, with a total 12-month return of +10.9% compared to the +9.5% return for the S&P 500 Index. These challenges include the rising cost of prescription drugs, the ongoing transition from fee-for-service to value-based reimbursement, and the uncertainty surrounding the Affordable Care Act . The company’s pharmacy business is expected to benefit from the continued growth of prescription drug sales, and the MinuteClinic business is expected to continue to grow as more Americans seek convenient, high-quality healthcare services.

Market Price

CVS Health Corporation has so far delivered strong results for investors, with the stock opening at $90.8 on Friday and closing at $89.3, down by 0.9% from the last closing price of $90.1. However, news about the company has been mostly positive, with analysts praising its recent acquisition of Aetna and its decision to stop selling cigarettes and other tobacco products.

VI Analysis

CVS Health is a large healthcare company with a wide range of businesses, from retail pharmacies to insurance plans. The company’s fundamentals reflect its long-term potential, and the VI app makes it easy to see where the company has strengths and weaknesses. Based on the VI Risk Rating, CVS Health is a medium risk investment in terms of financial and business aspects.

The app has detected three risk warnings in the income sheet, balance sheet, and non-financial areas. Registering on the app will give you access to more detailed information about these risks.

Summary

CVS Health Corporation is a major provider of healthcare services in the United States. The company has a strong track record of delivering strong results for investors. The company’s stock has outperformed the market over the past five years, and the company has a strong dividend yield.

CVS Health is a well-run company with a strong balance sheet and a commitment to shareholders. The company is a good investment for long-term investors.